$411.6K of planned sales filed in 30 days · 0.1% of the units outstanding
Filed 09/17
Technology sectorNasdaq
$411.6K of planned sales filed in 30 days · 0.1% of the units outstanding
Tang Capital Management holds 9.1% · +1.2pp on the report before
10/14 estimated earnings
13F filers: 104 · −2 since the quarter before · 06/30 holdings
Famous funds that held Nano Dimension in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| ARK Investment ManagementNano Dimension NNDM · 06/30 holdings | $1.8M | Trimmed −11.9% |
| Holder | ||
|---|---|---|
| Tang Capital Management08/21 | 9.1%19,232,538 sh | +1.2pp |
| Tang Capital Management07/27 | 7.9%16,715,812 sh | +1.1pp |
| Oramed Pharmaceuticals07/22 | 3.3%6,879,708 sh | −3.9pp |
| Murchinson07/20 | 8.1%17,136,276 sh | −1.5pp |
| Tang Capital Management06/30 | 6.8%14,292,813 sh | First report |
| Murchinson06/23 | 9.6%20,285,450 sh | +2.2pp |
| Oramed Pharmaceuticals06/17 | 7.2%15,079,708 sh | +2.0pp |
| Murchinson05/21 | 7.4%15,550,000 sh | No earlier report |
| Oramed Pharmaceuticals02/19 | 5.2%10,942,087 sh | +0.2pp |
| Oramed Pharmaceuticals01/29 | 5%10,549,430 sh | First report |
| Anson Funds Management25/07/14 | 4.2%9,057,952 sh | −3.3pp |
| Anson Funds Management25/07/03 | 7.5%16,361,433 sh | No earlier report |